New anti-clotting drug added to recommendations for treating irregular heartbeat
Monday, February 14, 2011 - 15:30
in Health & Medicine
A new anti-clotting drug, dabigatran, is added to recommendations for treating atrial fibrillation. Dabigatran is an alternative to the anti-clotting drug warfarin. Previous recommendations for warfarin still stand.